The AlphaLISA™ SureFire® Ultra™ Human Total TIE2 assay is a sandwich immunoassay for quantitative detection of total TIE2 in cellular lysates using Alpha technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Cell Signaling |
Sample Volume | 30 µL |
The AlphaLISA™ SureFire® Ultra™ Human Total TIE2 assay is a sandwich immunoassay for quantitative detection of total TIE2 in cellular lysates using Alpha technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
The TEK receptor tyrosine kinase (TIE2), encoded by the TEK gene in humans, is primarily expressed on endothelial cells. Upon binding with angiopoietin-1 (Angpt1), TIE2 induces angiogenesis and supports endothelial cell survival. This activation leads to downstream signaling pathways, including MEK/ERK, IKKb/NFkB, and AKT. Consequently, TIE2 contributes to vascular stability, cellular proliferation, inflammation, and cell survival. Elevated levels of Ang1 and/or Ang2 have been observed in patients with various cancers.
The AlphaLISA SureFire Ultra Human Total TIE2 Detection Kit is a sandwich immunoassay for the quantitative detection of total TIE2 in cellular lysates, using Alpha technology.
Formats:
AlphaLISA SureFire Ultra kits are compatible with:
Alpha SureFire kits can be used for:
Application |
Cell Signaling
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA SureFire Ultra
|
Detection Modality |
Alpha
|
Lysis Buffer Compatibility |
Lysis Buffer
|
Molecular Modification |
Total
|
Product Group |
Kit
|
Sample Volume |
30 µL
|
Shipping Conditions |
Shipped in Blue Ice
|
Target |
TIE2
|
Target Class |
Phosphoproteins
|
Target Species |
Human
|
Technology |
Alpha
|
Therapeutic Area |
Oncology
|
Unit Size |
100 Assay Points
|
HUVEC cells were seeded in a 96-well culture plate (20,000 cells/well) in complete medium and incubated for 48 hours at 37°C, 5% CO2. The cells were further treated with increasing concentrations of Pervanadate for 30 minutes.
After treatment, the cells were lysed with 50 µL of lysis buffer for 10 minutes at RT with shaking at 350 rpm. TIE2 Phospho (Tyr992) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays.
For the detection step, 10 µL of cell lysate (approximately 8,000 cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision Nexus™ using standard AlphaLISA settings.
Are you looking for resources, click on the resource type to explore further.
Optimizing AlphaLISA ™ Assays: Bead Pairing Recommendations
In AlphaLISA ™ assay design, selecting the right toolbox beads is...
We are here to answer your questions.